In the end, in silico docking was conducted for all proteins involved in the AGEs pathway (Table 3
Chang, A., Jeske, L., Ulbrich, S., Hofmann, J., Koblitz, J., Schomburg, I., Neumann-Schaal, M., Jahn, D., Schomburg, D
GLP-1 Receptor Agonist Market Competitive Landscape Major Competitors are: Other Competitors Include: GLP-1 Receptor Agonist Market Trends Major trends shaping the GLP-1 receptor agonist market include: Development Of Oral GLP-1 Candidates To Expand Patient Convenience And Treatment Accessibility Major companies in the GLP-1 receptor agonist market are focusing on the development of oral GLP-1 formulations designed to address rising global demand for more convenient, non-injectable metabolic therapies
Lee B, Chang SJ, Kwon BS, Son JH, Lim MC, Kim YH, et al
Curcumin suppresses in vitro proliferation and invasion of human prostate cancer stem cells by modulating DLK1-DIO3 imprinted gene cluster microRNAs